Fig. 1From: Safety and effectiveness of oral medium to high dose blonanserin in patients with schizophrenia: subgroup analysis from a prospective, multicenter, post-marketing surveillance study in mainland ChinaDaily dose of BNS in medium to high dose group over time (Mean ± SD)Back to article page